![The Radcliffe Cardiology Podcast](https://assets.radcliffecardiology.com/s3fs-public/podcast/2024-01/DELV-4317_IND_RadcliffePodcast_Brand_1080x1080%20%281%29.png?VersionId=0_xtiGz.9E0.ktP3ZIVRPtq5FM11oxcn)
The Radcliffe Cardiology Podcast
The Radcliffe Cardiology Podcast brings you the latest advancements, research and best practices in the field of cardiology. Each episode features expert insights and engaging discussions with leading healthcare professionals, covering a breadth of topics in cardiovascular science.
Our podcast aims to build on the best science, with key takeaways from the top cardiology conferences and recent publications from our journals.
Read MoreRead Less
All Episodes
![Targeting Inflammation in Atherosclerosis: Inflammation and Atherosclerosis](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-02/DELV-6313_NN_Kaski_Badimon_1920x1080_1.png?VersionId=NM38Vmrhd0rZkhpzvUCJ8Aj.5OoHyTxR&itok=z6D7Qx1D)
Inflammation and Atherosclerosis – What is the Link with CKD? Join Prof Juan Carlos Kaski (St George’s University of London, UK) and Prof Lina Badimon (Hospital of Santa Creu and San Pau, Barcelona, Spain) as they discuss that very question.
Read More
![Targeting Inflammation in Atherosclerosis: Therapeutic Targets and Mode of Action](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-02/DELV-6311_NN_Kaski_Libby_1920x1080.png?VersionId=CHVUI5Z6H9WM.EwmBKOybAd6OgTBpNLB&itok=wIYL79P-)
Prof Juan Carlos Kaski (St George’s University of London, UK) alongside Dr Peter Libby (Brigham and Women’s Hospital, Boston, US) provide us with a short and concise discussion regarding Therapeutic Targets and Mode of Action.
Read More
![Targeting Inflammation in Atherosclerosis: Inflammatory Signalling in Atherosclerosis and CKD](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-02/DELV-6312_NN_PP_Kaski_Ridker_Video2_1920x1080.png?VersionId=l4AvxX2wcAv0mjZ8HRrckn2.tQxPOoKd&itok=PcE6IpOJ)
Inflammatory Signalling in Atherosclerosis and CKD is the topic of interest in this short peer to peer discussion involving Prof Juan Carlos Kaski (St George’s University of London, UK) and Prof Paul Ridker (Brigham and Women’s Hospital, Boston, US).
Supported by an unrestricted educational grant from NOVO NORDISK A/S.
Read More
Supported by an unrestricted educational grant from NOVO NORDISK A/S.
![Targeting Inflammation in Atherosclerosis: Unmet Clinical Needs in Atherosclerosis and Chronic Kidney Disease](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-02/DELV-6312_NN_PP_Kaski_Ridker_Video1_1920x1080.png?VersionId=o6Ai1eALt9goiQGMnx3u011gF5Lik1Gr&itok=aGaoYZr7)
Prof Juan Carlos Kaski (St George’s University of London, UK) is joined by Prof Paul Ridker (Brigham and Women’s Hospital, Boston, US) to discuss Unmet Clinical Needs in Atherosclerosis and Chronic Kidney Disease where they cover topics such as elevated hsCRP and chronic kidney disease.
Read More
![Targeting Inflammation in Atherosclerosis: COLCOT Trial](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-02/DELV-6319_NN_Tardif_1920x1080.png?VersionId=IZkLxvnDuTsja5S6DvQZ1xpITal5wiu4&itok=XK-jErQu)
Prof Jean-Claude Tardif (Montreal Heart Institute, Canada) gives us a comprehensive overview of the COLCOT trial.
Read More
![Targeting Inflammation in Atherosclerosis: LoDoCo2 Trial](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-02/DELV-6316_NN_Fiolet_1920x1080.png?VersionId=AL_yCpLqvIZMkLbADH_U3FeRdEkaA_fD&itok=h9afQebj)
In this LoDoCo2 presentation, Dr Aernoud Fiolet (University Medical Center Utrecht, Netherlands) covers the trial design and main results.
Supported by an unrestricted educational grant from NOVO NORDISK A/S.
Read More
Supported by an unrestricted educational grant from NOVO NORDISK A/S.
![Targeting Inflammation in Atherosclerosis: RESCUE Trial](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-02/DELV-6318_NN_Libby_1920x1080.png?VersionId=2HrXL_1dVMbJ9BJrgEizEE2AotHOWbYt&itok=9UTzPFNn)
Join Dr Peter Libby (Brigham and Women’s Hospital, Boston, US) as he talks us through the RESCUE trial design and results in this short podcast.
Read More
![Targeting Inflammation in Atherosclerosis: CANTOS Trial](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-02/DELV-6317_NN_Ridker_1920x1080.png?VersionId=BgTEwlHOTtN9IR0YhA3XyQs1_ZBQDD_p&itok=WJnbP8uu)
Prof Paul Ridker (Brigham and Women’s Hospital, Boston, US) provides us with an overview of the CANTOS main trial results and updated results from the ACC 2022.
Read More
![Ep 5: Invasive Diagnosis of Coronary Functional Disorder](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2023-02/DELV-7457_ECR_EP_5_1920x1080%20v3.png?VersionId=IAiK7R0cREVP1Gq471L8LCSsiRQZpbx5&itok=ARtHzoxY)
Did you know that coronary vasomotion disorders are a frequent cause of angina in patients with non-obstructed coronary arteries? In this month's episode of the ECR podcast, Dr Andreas Seitz and Dr Peter Ong (Robert-Bosch Hospital, Stuttgart, DE) return to discuss their recent article on the diagnosis of coronary disorders which cause angina (https://www.ecrjournal.com/articles/invasive-diagnosis-coronary-functional-disorders-causing-angina-pectoris) from ECR Journal.
Read More
![Ep 4: The EXCEL Trial: The Interventionalists’ Perspective](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2023-02/DELV-5953_ECR_EP_4_1920x1080%20v3.png?VersionId=S3ZFF0CWhO9XD4zbfg402A8aoXUsnzgn&itok=A4Q6m6BN)
In this month's featured author episode of the ECR Podcast, interventional fellow Dr George Hunter (Bedfordshire Hospitals NHS Foundation Trust, Bedford, UK) discusses the EXCEL trial from his perspective as a member of the PCI community, based on a recent review paper from the ECR Journal. In this podcast, Dr Hunter discusses the controversy surrounding the trial and the importance of studying left main stem disease in cardiology today.
Read More
![European Examination in Core Cardiology: APSC Exit Examination](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2023-03/DELV-13669_IND_JAPSC_EP_1_1920x1080.png?VersionId=_8w3YjYZxRnnVGkNVlR32WkHx4ef7Ijw&itok=YV5dcNYp)
In this episode of the Radcliffe Cardiology Podcast, we are joined by Dr Jack Tan (National Heart Centre, SG) and Dr Chris Plummer (The Newcastle upon Tyne Hospitals NHS Foundation Trust, UK), who provide an overview of a recent JAPSC Journal article based on the European Examination in Core Cardiology.
Read More
![View from the Thoraxcenter: What's Hot at ACC.23?](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-02/MicrosoftTeams-image%20%285%29%20%281%29.png?VersionId=EkO4xhYtwePQNEaHyDbtfM0MSuOxjgkh&itok=-x-DpRKp)
In this episode of "View from the Thoraxcenter," Prof Nicolas Van Mieghem and Dr Joost Daemen preview the most anticipated late-breaking and featured science trials of ACC.23 and discuss their potential impact on patient care and research.
Read More
![Ep 1: Breaking the Cycle of HFpEF and Atrial Fibrillation](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2023-02/DELV-12902_IND_CFR_EP_1_1920x1080.png?VersionId=TzS65EpdM.JsJxP.B1eP_v9y5IAzpG.o&itok=hPMTCbVj)
In this episode, key discussion topics include: - Diagnosis, treatment and patient wellbeing for comorbid HFpEF and AF - Adverse event rates and prognostic implications for HFpEF and AF, and how we can close the gaps in the diagnostic challenges - Approaches and critical steps to patient management.
Read More
![Ep 11: Sex Differences in Hypertension: Diagnosis, Awareness, and Control](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2023-02/DELV-11091_ECR_EP_11_1920x1080%20v3.png?VersionId=HEPtOUkoJnFkOQ8cH3Qp.vkhUwZvtp1r&itok=OBLNLrMc)
In the third part of ECR Podcast's series on sex-differences in hypertension, Dr Isabella Sudano (University Hospital and University of Zurich, Zurich, CH) and Dr Eva Gerdts (Haukeland University Hospital, Bergen, NO) are joined by Prof Renata Cifkova (Institute of Experimental Medicine, Prague, CZ) to discuss the diagnosis of hypertension in women, including how we can raise awareness for this issue.
Read More
![Ep 10: Sex Differences in Hypertension: Cardiovascular complications](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2023-02/DELV-9617_ECR_EP_10_1920x1080%20v3.png?VersionId=311gS_Qql6xzcHJdonGWujbd7FLMgB_H&itok=KlyNfAc_)
In the second part of ECR Podcast's series on sex-differences in hypertension, Dr Isabella Sudano (University Hospital and University of Zurich, Zurich, CH) and Dr Eva Gerdts (Haukeland University Hospital, Bergen, NO) are joined by Dr Angela Maas (Radboud University Medical Center, Nijmegen, NL) to talk about the cardiovascular complications that may arise in women as a result of hypertension.
Read More